


Scottish Medicines Consortium Recommends Risankizumab; Plus Real-World Data on Secukinumab

Japan Approves Risankizumab for Psoriasis & Psoriatic Arthritis
For Psoriasis, Ustekinumab & TNF Inhibitors Show Similar Cardiac Safety

Patients with Psoriatic Arthritis at Increased Risk for Type 2 Diabetes

Piclidenoson in Trials for Psoriasis & RA; Plus Duzallo Approved in Europe
Adalimumab Appears Safe for Treating Pediatric Patients with Autoimmune Disease

Dietary Recommendations for Psoriasis Patients

Certolizumab Pegol Receives FDA Approval for Plaque Psoriasis

FDA Updates Ixekizumab Label to Include Genital Area Psoriasis
- 1
- 2
- 3
- …
- 7
- Next Page »